Bioventus (NASDAQ:BVS) Shares Down 8.2% – Here’s Why

Bioventus Inc. (NASDAQ:BVS)’s stock price was down 8.2% on Friday . The company traded as low as $8.32 and last traded at $8.35. Approximately 154,082 shares were traded during trading, a decline of 43% from the average daily volume of 272,240 shares. The stock had previously closed at $9.10.

Wall Street Analyst Weigh In

A number of analysts have issued reports on BVS shares. Cantor Fitzgerald upgraded shares of Bioventus to a “strong-buy” rating in a report on Wednesday. Weiss Ratings restated a “hold (c-)” rating on shares of Bioventus in a research report on Monday, December 29th. Finally, Barrington Research upgraded Bioventus to a “strong-buy” rating in a research report on Monday, February 9th. Two research analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Bioventus has an average rating of “Buy”.

Bioventus Price Performance

The firm has a market cap of $693.53 million, a P/E ratio of 69.84 and a beta of 0.78. The company has a debt-to-equity ratio of 1.50, a current ratio of 1.74 and a quick ratio of 1.14. The stock’s 50-day simple moving average is $8.10 and its two-hundred day simple moving average is $7.49.

Bioventus (NASDAQ:BVS) last released its earnings results on Thursday, March 5th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.02. The firm had revenue of $157.90 million during the quarter. Bioventus had a net margin of 1.39% and a return on equity of 26.38%.

Bioventus Company Profile

Bioventus, headquartered in Durham, North Carolina, is a global medical device company specializing in orthobiologic solutions aimed at accelerating healing and improving patient outcomes in musculoskeletal conditions. The company develops and commercializes a portfolio of non‐surgical therapies designed to address bone healing, osteoarthritis pain management and soft tissue repair. Its flagship EXOGEN® Ultrasound Bone Healing System utilizes low‐intensity pulsed ultrasound technology to stimulate bone growth and has been widely used in the management of delayed fractures and nonunions.